JT
Insider
Joseph A. Tyndall
DirectorJoseph A. Tyndall (Director) filed 2 Form 4 reports in the trailing twelve months (0 purchases, 2 sales), most often in Axogen, Inc. (AXGN). The largest single filing was $778K of AXGN (25,108 sh across 2 lots, as filed), executed Dec 9 2025.
Add to watchlistReturn, ttmiAverage return per filing, trailing twelve months
–
no purchases on file
Delay-adjustediThe same average, entered at disclosure dates
–
returns measure stock purchases only
Filings, ttm
2
0 buys · 2 sells
Median delay
–
execution → disclosure
Volume, ttmiDollar value disclosed in the trailing twelve months
$952K
shares × price, as filed
Last traded
Sep 2
Filed Sep 4
Median ADV $60.7M across their filed names
Open performance→Volume by month
Buys $0
Sells $1.4M
Shares × price, as filed · by filing month · past 24 months
Sectors filed on
Healthcare
2 filings
Sector per market data · by filing · past 12 months
Most traded names
AXGNRecent filings
AXGNSALE
Axogen, Inc.
View filing →
$174K3,500 sh × $49.70
Exec Sep 2
Filed Sep 4 · 4:08 PM ET AXGNSALE Axogen, Inc. View filing → $778K
25,108 sh across 2 lots
Exec Dec 9 2025
Filed Dec 10 2025 · 5:30 PM ET AXGNSALE Axogen, Inc. View filing → $289K
26,931 sh × $10.72
Exec Jun 10 2025
Filed Jun 11 2025 · 5:30 PM ET AXGNSALE Axogen, Inc. View filing → $144K
12,850 sh × $11.20
Exec May 22 2025
Filed May 23 2025 · 5:30 PM ET